World Health Organization, United Nations Development Programme (UNDP)
Pacific NCD Summit: Translating global and regional commitments into local action
Report
08 May 2024
01 Oct 2022
This systematic review, commissioned by WHO, explored the availability, cost and affordability of essential medicines for asthma and COPD in LMICs in published literature between 2010-2022. Inhaled medicines were largely unavailable and unaffordable – this was particularly true for inhalers containing corticosteroids.